HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Portfolio Tracker
Get an update on your stocks every day. See earnings revisions, new reports and Zacks Rank changes at a glance. Click here to learn more.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

NEOG: Neogen Cp - Full Company Report Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Full Company Report |  Estimates |  Brokerage Recommendations |  Comparison to Industry |  Insiders |  Brokerage Reports |  Zacks Equity Research   |  Annual Report
NEOGEN CP (NASD)
NEOG 33.85 0.64 (1.93%) Vol.  15,508 11:52 ET
Neogen Corporation develops, manufactures, and markets a diverse line ofproducts dedicated to food and animal safety. The company's food safety segment consists primarily of diagnostic test kits and related products, including dehydrated culture media, marketed to food producers and processors to aid in the detection of foodborne bacteria, natural toxins, food allergens, drug residues, pesticide residues, plant disease infections and levels of general sanitation.

 General Information
NEOGEN CORP
620 Lesher Place
Lansing, MI 48912
Phone: 517 372-9200
Fax: 517-372-2006
Web: www.neogen.com
Email: ir@neogen.com
 
Industry MED PRODUCTS
Sector: Medical
 
Fiscal Year End May
Last Reported Quarter 08/31/09
Next EPS Date 01/05/2010
 
 Price and Volume Information
Zacks Rank
Yesterday's Close 33.21
52 Week High 34.18
52 Week Low 16.50
Beta 0.68
20 Day Moving Average 53,089.10
Target Price Consensus 35.25
 
 % Price Change
4 Week 3.10
12 Week 17.60
YTD 32.95
 % Price Change Relative to S&P 500
4 Week 1.99
12 Week 10.87
YTD 10.03
 Share Information
Shares Outstanding (millions) 15.00
Market Capitalization (millions) 498.15
Short Ratio 11.43
Last Split Date 09/05/2007
 Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

 EPS Information
Current Quarter EPS Consensus Estimate 0.29
Current Year EPS Consensus Estimate 1.09
Estimated Long-Term EPS Growth Rate 18.20
Next EPS Report Date 01/05/2010
 Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell) 1.67
30 Days Ago 1.67
60 Days Ago 1.67
90 Days Ago 1.67

 Fundamental Ratios
 P/E
Current FY Estimate: 30.42
Trailing 12 Months: 34.24
PEG Ratio 1.67
 EPS Growth
vs. Previous Year 16.00%
vs. Previous Quarter 26.09%
 Sales Growth
vs. Previous Year 12.30%
vs. Previous Quarter: 4.72%
 Price Ratios
Price/Book 3.64
Price/Cash Flow 27.62
Price / Sales 4.07
 ROE
08/31/09 11.42
05/31/09 11.31
02/28/09 11.52
 ROA
08/31/09 10.19
05/31/09 10.05
02/28/09 10.16
 Current Ratio
08/31/09 6.55
05/31/09 7.77
02/28/09 6.26
 Quick Ratio
08/31/09 4.09
05/31/09 4.37
02/28/09 3.45
 Operating Margin
08/31/09 11.89
05/31/09 11.69
02/28/09 11.86
 Net Margin
08/31/09 18.61
05/31/09 18.21
02/28/09 18.11
 Pre-Tax Margin
08/31/09 18.61
05/31/09 18.21
02/28/09 18.11
 Book Value
08/31/09 9.11
05/31/09 8.71
02/28/09 8.48
 Inventory Turnover
08/31/09 1.92
05/31/09 1.89
02/28/09 1.87
 Debt-to-Equity
08/31/09 0.00
05/31/09 0.00
02/28/09 0.00
 Debt to Capital
08/31/09 0.00
05/31/09 0.00
02/28/09 0.00

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research